Bellicum Pharmaceuticals Competitors and Similar CompaniesClear all

Bellicum Pharmaceuticals's competitors and similar companies include Celyad, Bluebird Bio, Allogene Therapeutics and Adaptimmune.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing cellular immunotherapies.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Allogene Therapeutics
Allogene Therapeutics
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
Adaptimmune
Adaptimmune
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
Founding Date
Founding Date
2004
Founding Date
2007
Founding Date
1992
Founding Date
2018
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Houston, US HQ
Houston, US
Houston, US
South San Francisco, US
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Somerville, US HQ
Locations
South San Francisco, US HQ
Locations
Philadelphia, US HQ
Milton, GB
Milton, GB
Stevenage, GB
Employees
Employees
1386% increase
Employees
35
Employees
32338% decrease
Employees
35917% increase
Employees
4007% decrease
Valuation ($)
Valuation ($)
778.3 k
Valuation ($)
15.9 m
Valuation ($)
198.5 m
Valuation ($)
642.5 m
Valuation ($)
296.5 m
Twitter followers
Twitter followers
588
Twitter followers
2.4 k
Twitter followers
10.6 k
Twitter followers
2.2 k
Twitter followers
3.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
5.1
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
8.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
50%
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%

Financial

Revenue (est.)
Revenue (est.)
$1.5m (FY, 2022)
Revenue (est.)
N/A
Revenue (est.)
$3.6m (FY, 2022)
Revenue (est.)
$243k (FY, 2022)
Revenue (est.)
$60.3m (FY, 2023)
Net income
Net income
($25m) (FY, 2022)
Net income
(€40.9m) (FY, 2022)
Net income
($266.6m) (FY, 2022)
Net income
($332.6m) (FY, 2022)
Net income
($113.9m) (FY, 2023)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 409m
Total funding raised
$ 532m
Total funding raised
$ 107.5m
For sources of this data, please see the company profile

View Company Profiles

Celyad
HQ
Mont-Saint-Guibert, BE
Employees
35

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company
Allogene Therapeutics
HQ
South San Francisco, US
Employees
359↑ 17% increase

Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.

View company
Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease

Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

View company